Table 1.
Patient and clinical parameters for the patient population with esophageal and lung cancer used for this study
| Parameter | No. (%) |
|---|---|
| Lung cancer population | |
| No. of patients | 35 |
| Sex | |
| Female | 20 (57) |
| Male | 15 (43) |
| COPD/emphysema | |
| Yes | 22 (63) |
| No | 13 (37) |
| Smoking status | |
| Nonsmoker | 5 (14) |
| Current smoker | 6 (17) |
| Former smoker | 24 (69) |
| Histology | |
| NSCLC | 33 (94) |
| SCLC | 2 (6) |
| Stage | |
| IIB | 1 (3) |
| IIIA | 17 (49) |
| IIIB | 14 (40) |
| IV | 3 (8) |
| Treatment regimens | |
| 60 Gy (30 fr of 2 Gy) | 18 (51) |
| 50 Gy (25 fr of 2 Gy) | 7 (20) |
| 50.04 Gy (28 fr of 1.8 Gy) | 8 (23) |
| 45 Gy (30 fr of 1.5 Gy) | 2 (6) |
| Esophageal cancer population | |
| No. of patients | 35 |
| Sex | |
| Female | 9 (26) |
| Male | 26 (74) |
| COPD/emphysema | |
| Yes | 8 (23) |
| No | 27 (77) |
| Smoking status | |
| Nonsmoker | 11 (31) |
| Current smoker | 4 (12) |
| Former smoker | 20 (57) |
| Histology | |
| Adenocarcinoma | 29 (83) |
| Squamous cell carcinoma | 6 (17) |
| Stage | |
| IB | 3 (8.5) |
| IIA | 8 (23) |
| IIB | 2 (5.5) |
| IIIA | 8 (23) |
| IIIB | 8 (23) |
| IIIC | 3 (8.5) |
| IV | 3 (8.5) |
| Treatment regimens | |
| 60 Gy (30 fr of 2 Gy) | 1 (3) |
| 50 Gy (25 fr of 2 Gy) | 12 (34) |
| 50.4 Gy (28 fr of 1.8 Gy) | 15 (43) |
| 45 Gy (25 fr of 1.8 Gy) | 7 (20) |
Abbreviations: COPD = chronic obstructive pulmonary disease; fr = fraction; NSCLC = non-small cell lung cancer; SCLC = small cell lung cancer.